-
1
-
-
0028156958
-
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
-
Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 8-19
-
-
Kessler, R.C.1
McGonagle, K.A.2
Zhao, S.3
-
3
-
-
0032814021
-
Panic disorder in the primary care setting: Comorbidity, disability, service utilization, and treatment
-
Roy-Byrne PP, Stein MB, Russo J, et al. Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry. 1999;60:492-499.
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 492-499
-
-
Roy-Byrne, P.P.1
Stein, M.B.2
Russo, J.3
-
5
-
-
0011876346
-
Clinical approach to treatment-resistant panic
-
Rosenbaum JF, Pollack MH, eds. New York: Dekker
-
Roy-Byrne P, Cowley D. Clinical approach to treatment-resistant panic. In: Rosenbaum JF, Pollack MH, eds. Panic Disorder and Its Treatment. New York: Dekker; 1998:205-228.
-
(1998)
Panic Disorder and Its Treatment
, pp. 205-228
-
-
Roy-Byrne, P.1
Cowley, D.2
-
6
-
-
0033044469
-
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders
-
Uhlenhuth EH, Balter MB, Ban TA, Yang K. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders. Depress Anxiety. 1999;9:107-116.
-
(1999)
Depress Anxiety
, vol.9
, pp. 107-116
-
-
Uhlenhuth, E.H.1
Balter, M.B.2
Ban, T.A.3
Yang, K.4
-
7
-
-
0028922375
-
Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: A meta-analysis
-
Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol. 1995;10:45-49.
-
(1995)
Int Clin Psychopharmacol
, vol.10
, pp. 45-49
-
-
Boyer, W.1
-
8
-
-
0023086643
-
Effect of serotonin uptake inhibitors in anxiety disorders: A double-blind comparison of clomipramine and fluvoxamine
-
den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol. 1987;2:21-32.
-
(1987)
Int Clin Psychopharmacol
, vol.2
, pp. 21-32
-
-
Den Boer, J.A.1
Westenberg, H.G.2
Kamerbeek, W.D.3
Verhoeven, W.M.4
Kahn, R.S.5
-
9
-
-
0026650901
-
Superiority of clomipramine over imipramine in the treatment of panic disorder: A placebo-controlled trial
-
Modigh K, Westberg P, Eriksson E. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial. J Clin Psychopharmacol 1992;12:251-261.
-
(1992)
J Clin Psychopharmacol
, vol.12
, pp. 251-261
-
-
Modigh, K.1
Westberg, P.2
Eriksson, E.3
|